Bioké Inks Distribution Deal for Advanced Cell Diagnostics Products in Benelux Region | GenomeWeb
Home » Bioké Inks Distribution Deal for Advanced Cell Diagnostics Products in Benelux Region

Bioké Inks Distribution Deal for Advanced Cell Diagnostics Products in Benelux Region

Jun 07, 2012
|
a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioké and Advanced Cell Diagnostics today announced a distribution deal covering the Benelux region.

Under the terms of the deal, which took effect on May 1, Bioké will promote, sell, and provide technical and customer support for ACD products in Belgium, Luxembourg, and the Netherlands. Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jan 26, 2016

Leica Biosystems, Advanced Cell Diagnostics Partner to Develop Dx Tests With RNAscope Technology

Jul 07, 2016

Bio-Techne Acquires Advanced Cell Diagnostics for $250M

Oct 13, 2015

Bioké Distributing Horizon Discovery Reference Standards in Netherlands

Apr 15, 2016

Leica Biosystems, Merrimack Pharma Collaborate on Companion Dx

Sep 01, 2016

Horizon, Ventana Partner on IHC Reference Standards for Cancer Tissue Diagnostics

Sep 09, 2016

WuXi to Distribute AutoGenomics' MDx System in China

The Scan

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

Choice Against Testing

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

Call for Gene Editing Oversight

The Japan Times says regulations are needed to oversee human genome-editing research.

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

What's Popular?

In Clinical & Translational

  1. Myriad Files Lawsuit Against Ambry Genetics for Infringing Patent Claims Underlying BRCA Test

  2. NGS-Based Peptide Display Platform Enables Proteome-Wide Screening for Autoantigens

    Premium

  3. FDA, Correlogic, Transgenomic, Lark Technologies, OpGen, Paradigm Genetics, Gene Logic, TherImmune, Third Wave, Biotage, Agencourt Bioscience, CombiMatrix

    Premium

  4. PCR Firm QuantaLife Raises $17.2M in Series B

  5. Illumina to Acquire Verinata for up to $450M

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.